← all drugs
Liraglutide Injection
in shortage · Endocrinology/Metabolism · Snapshot: 2026-08-25
Day 1,134
of this shortage, counting from the FDA's first posting on 07/18/2023
- Manufacturers listed
- Hikma Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc., Novo Nordisk, Inc., Meitheal Pharmaceuticals, Inc.
- Reported reason(s)
- Delay in shipping of the drug; Other
- Machine-readable
- JSON for this drug
Presentations (10)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03) | Hikma Pharmaceuticals USA, Inc. | Available | 08/13/2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46) | Teva Pharmaceuticals USA, Inc. | unknown | 05/14/2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22) | Novo Nordisk, Inc. | Available | 08/17/2026 |
| Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12) | Novo Nordisk, Inc. | Limited Availability | 08/17/2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85) | Meitheal Pharmaceuticals, Inc. | Limited Availability | 06/01/2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02) | Hikma Pharmaceuticals USA, Inc. | Available | 08/13/2026 |
| Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13) | Novo Nordisk, Inc. | Limited Availability | 08/17/2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84) | Meitheal Pharmaceuticals, Inc. | Available | 06/01/2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20) | Novo Nordisk, Inc. | Available | 08/17/2026 |
| Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Novo Nordisk, Inc. | Available | 08/17/2026 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.